logo

For the Inventor, By the Inventor

Haarlem, Netherlands

Cornelis Johannes Maria Melief

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 50(Granted Patents)


Company Filing History:

goldMedal6 out of 37 
 
Academisch Ziekenhuis Leiden (h.o.d.n. Lumc)
 patents
silverMedal4 out of 47 
 
Academisch Ziekenhuis Leiden
 patents
bronzeMedal2 out of 6 
 
Isa Pharmaceuticals B.v.
 patents
4. 1 out of 15 
 
Leiden University Medical Center
 patents
5. 1 out of 2 
 
Leids Universitair Medisch Centrum
 patents
6. 1 out of 832,718 
Other
 patents

Years Active: 2007-2022

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11458198 - HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines (2022-10-04),
2. 10688173 - HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines (2020-06-23),
3. 10450356 - PRAME derived peptides and immunogenic compositions comprising these (2019-10-22),
4. 10258684 - HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines (2019-04-16),
5. 10253073 - Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses (2019-04-09),
6. 9770506 - Adjuvant compound (2017-09-26),
7. 9650423 - Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses (2017-05-16),
8. 9562075 - Intradermal HPV peptide vaccination (2017-02-07),
9. 9441025 - Prame derived peptides and immunogenic compositions comprising these (2016-09-13),
10. 9314521 - Adjuvant compound (2016-04-19),
11. 9115185 - Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses (2015-08-25),
12. 8663646 - P53 peptide vaccine (2014-03-04),
13. 7807369 - Methods and means for the treatment of HPV induced intraepithelial neoplasia (2010-10-05),
14. 7560105 - Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses (2009-07-14),
15. 7202034 - Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses (2007-04-10),

Title: The Innovative Journey of Cornelis Johannes Maria Melief

Introduction: Cornelis Johannes Maria Melief, a distinguished inventor hailing from Haarlem, NL, has made significant contributions to the field of science and technology through his groundbreaking innovations.

Latest Patents: Cornelis Johannes Maria Melief's latest patents focus on novel methods for enhancing immune responses in the treatment of various diseases, particularly in the realm of oncology and infectious diseases.

Career Highlights: With a career spanning several decades, Cornelis Johannes Maria Melief has held key positions in renowned research institutions and universities, where he has spearheaded pioneering research projects that have led to the development of cutting-edge technologies.

Collaborations: Throughout his career, Cornelis Johannes Maria Melief has collaborated with leading scientists, researchers, and pharmaceutical companies to further the advancement of his inventions. His collaborative efforts have resulted in the successful translation of his innovative ideas into tangible products that have positively impacted society.

Conclusion: Cornelis Johannes Maria Melief's relentless pursuit of innovation and his unwavering commitment to scientific excellence have solidified his position as a trailblazer in the world of inventions. His contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…